Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine

NCT07719608 is registered in ClinicalTrials.gov with Salvia BioElectronics as lead sponsor.

NCT NCT07719608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07719608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine
Lead sponsor
Salvia BioElectronics
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2026
Completion date
May 1, 2031
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine headache, headache (migraine), headache, cluster, resistant migraine